Bahareh Attaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bahareh Attaran has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Marjan Mohammadi
HPGC Research Group, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
4 shared publications - Tahereh Falsafi
Microbiology Department, Faculty of Biological Sciences, Alzahra University, Tehran, Iran
4 shared publications Maryam Esmaeili
HPGC Research Group, Department of Medical Biotechnology, Pasteur Institute of Iran, Tehran, Iran
3 shared publications- Najmeh Salehi
Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
3 shared publications Bahareh Ghadiri
HPGC Research Group, Department of Medical Biotechnology, Pasteur Institute of Iran, Tehran, Iran
2 shared publicationsMahmoud Eshagh Hosseini
Gastroenterology Department, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 28 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Exploring feature limitations in antimicrobial resistance prediction: machine learning and deep learning in A. baumannii
Antimicrobial resistance phenotype prediction (AMRPP) provides a computational alternative to conventional susceptibility testing. While most studies focus on single antibiotics, systematic multi-antibiotic modeling and optimal strain representation remain underexplored. Acinetobacter baumannii (A. baumannii), designated by the World Health Organization as a critical priority pathogen, still lacks a comprehensive computational investigation. This study introduces a multi-antibiotic framework for AMRPP in A. baumannii, in which strains are encoded by gene presence/ absence (GPA) profiles. We evaluate whether these features contain sufficient predictive information for classical machine learning (ML) models or require advanced deep learning (DL) architectures. To enhance the representational informativeness and mitigate the high dimensionality of GPA features, four strategies are applied: pathway-based filtering using KEGG, statistical selection by information content (IC), unsupervised reduction via PCA, and model-driven explainability selection with SHAP. Moreover, strong ML baselines: support vector machines, random forests, and extreme gradient boosting (XGB), are benchmarked against a custom DL model, TripSimAcin-AMR, a three-subnetwork siamese neural network tailored for limited data. According to the results, Data-driven representations (PCA, IC, SHAP) outperform KEGG-based filtering, achieving an overall performance of 92.64–93.16%. TripSimAcin-AMR and XGB yield comparable accuracy, but TripSimAcin-AMR achieves higher specificity (85.17% vs. 78.77%). From a clinical perspective, this high specificity is particularly crucial, as false-positive resistance predictions can mislead clinicians to avoid effective first-line antibiotics and unnecessarily escalate to broad-spectrum or last-line therapies. The best configuration, TripSimAcin-AMR with IC-based features, reaches 94.2% accuracy, 94.2% AUC-ROC, 97.0% sensitivity, and 91.3% specificity, underscoring the potential of enriched GPA representations for robust AMR prediction.
- 28 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessExploring feature limitations in antimicrobial resistance prediction: machine learning and deep learning in A. baumannii
Antimicrobial resistance phenotype prediction (AMRPP) provides a computational alternative to conventional susceptibility testing. While most studies focus on single antibiotics, systematic multi-antibiotic modeling and optimal strain representation remain underexplored. Acinetobacter baumannii (A. baumannii), designated by the World Health Organization as a critical priority pathogen, still lacks a comprehensive computational investigation. This study introduces a multi-antibiotic framework for AMRPP in A. baumannii, in which strains are encoded by gene presence/ absence (GPA) profiles. We evaluate whether these features contain sufficient predictive information for classical machine learning (ML) models or require advanced deep learning (DL) architectures. To enhance the representational informativeness and mitigate the high dimensionality of GPA features, four strategies are applied: pathway-based filtering using KEGG, statistical selection by information content (IC), unsupervised reduction via PCA, and model-driven explainability selection with SHAP. Moreover, strong ML baselines: support vector machines, random forests, and extreme gradient boosting (XGB), are benchmarked against a custom DL model, TripSimAcin-AMR, a three-subnetwork siamese neural network tailored for limited data. According to the results, Data-driven representations (PCA, IC, SHAP) outperform KEGG-based filtering, achieving an overall performance of 92.64–93.16%. TripSimAcin-AMR and XGB yield comparable accuracy, but TripSimAcin-AMR achieves higher specificity (85.17% vs. 78.77%). From a clinical perspective, this high specificity is particularly crucial, as false-positive resistance predictions can mislead clinicians to avoid effective first-line antibiotics and unnecessarily escalate to broad-spectrum or last-line therapies. The best configuration, TripSimAcin-AMR with IC-based features, reaches 94.2% accuracy, 94.2% AUC-ROC, 97.0% sensitivity, and 91.3% specificity, underscoring the potential of enriched GPA representations for robust AMR prediction.
- Open Access
- 25 May 2024
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 18 (2) , 80-88
Isolation, Identification and Antibiotic Resistance of Anaerobic Bacteria in Sputum of Cystic Fibrosis Patients from Children's Medical Center of Tehran, Iran
Background and Aim: Following genetic defects in cystic fibrosis (CF), mucus accumulation and hypoxic gradients develop in the lungs creating conditions for the anaerobic bacterial colonization. This study investigated the difference between the prevalence of some anaerobic bacteria and antibiotic resistance among healthy and CF groups. Materials and Methods: In this research, ...
- 25 May 2024
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 18 (2) , 80-88
Open AccessIsolation, Identification and Antibiotic Resistance of Anaerobic Bacteria in Sputum of Cystic Fibrosis Patients from Children's Medical Center of Tehran, Iran
Background and Aim: Following genetic defects in cystic fibrosis (CF), mucus accumulation and hypoxic gradients develop in the lungs creating conditions for the anaerobic bacterial colonization. This study investigated the difference between the prevalence of some anaerobic bacteria and antibiotic resistance among healthy and CF groups. Materials and Methods: In this research, ...
- 21 June 2022
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 21 (3) , 241-253
Neutrophil to Lymphocyte Ratio (NLR) and Derived NLR Combination: A Cost-effective Predictor of Moderate to Severe COVID-19 Progression
Inflammation is an essential contributor to Coronavirus disease 2019 (COVID-19). In this regard, finding a prognostic indicator is valuable because the treatment will be more effective if critical patients with high inflammation are diagnosed earlier. We aimed to evaluate some hematologic markers for COVID-19 and assess their association with the severity of the disease. A total of 154 COVID-19 patients were laboratory-confirmed and admitted to Imam Khomeini Hospital Complex, Tehran, Iran, from February 12, 2020, to April 4, 2020, and 55 healthy individuals were enrolled in the study. The severity of the patients' illnesses was classified into three subgroups according to the types of oxygen therapies (moderate (61), severe (28), and critical (43)) and examined the different ratios of total white blood cell (WBC) count, neutrophil to lymphocyte ratio (NLR), platelet to monocyte ratio (PLR), macrophage to lymphocyte ratio (MLR), derived NLR ratio (dNLR), and some biochemical tests. COVID-19 patients had higher levels of NLR, MLR, PLR, and dNLR than healthy subjects. receiver operating characteristic (ROC) analysis of the curve revealed that NLR and dNLR had a high diagnostic value to differentiate COVID-19 patients from healthy subjects (area under the curve [AUC]=0.923 and 0.910, respectively) and predict mortality (AUC=0.726 and 0.735, respectively). NLR and dNLR may be reliable markers to evaluate the severity of COVID-19. NLR and dNLR had a high diagnostic value for differentiating COVID-19 patients from healthy subjects, and they could predict the severity and outcome of the disease.
- 21 June 2022
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 21 (3) , 241-253
Neutrophil to Lymphocyte Ratio (NLR) and Derived NLR Combination: A Cost-effective Predictor of Moderate to Severe COVID-19 Progression
Inflammation is an essential contributor to Coronavirus disease 2019 (COVID-19). In this regard, finding a prognostic indicator is valuable because the treatment will be more effective if critical patients with high inflammation are diagnosed earlier. We aimed to evaluate some hematologic markers for COVID-19 and assess their association with the severity of the disease. A total of 154 COVID-19 patients were laboratory-confirmed and admitted to Imam Khomeini Hospital Complex, Tehran, Iran, from February 12, 2020, to April 4, 2020, and 55 healthy individuals were enrolled in the study. The severity of the patients' illnesses was classified into three subgroups according to the types of oxygen therapies (moderate (61), severe (28), and critical (43)) and examined the different ratios of total white blood cell (WBC) count, neutrophil to lymphocyte ratio (NLR), platelet to monocyte ratio (PLR), macrophage to lymphocyte ratio (MLR), derived NLR ratio (dNLR), and some biochemical tests. COVID-19 patients had higher levels of NLR, MLR, PLR, and dNLR than healthy subjects. receiver operating characteristic (ROC) analysis of the curve revealed that NLR and dNLR had a high diagnostic value to differentiate COVID-19 patients from healthy subjects (area under the curve [AUC]=0.923 and 0.910, respectively) and predict mortality (AUC=0.726 and 0.735, respectively). NLR and dNLR may be reliable markers to evaluate the severity of COVID-19. NLR and dNLR had a high diagnostic value for differentiating COVID-19 patients from healthy subjects, and they could predict the severity and outcome of the disease.
- Open Access
- 22 February 2022
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 14 (1) , 84-89
Evaluation of the frequency of Escherichia coli pathogroups in Brassica oleracea cultivars
Background and Objectives: Pathogenic diseases resulting from microbial contamination of food have been widely distrib- uted in many parts of the world. Among these, Escherichia coli is one of the most important foodborne pathogenic bacteria. Diarrhea is one of the major causes of children’s death in developing countries, with approximately 2 million deaths annually. The current study aimed to determine the frequency of diarrheagenic E. coli pathotypes such as Enteropathogenic E. coli (EPEC), Enterotoxigenic E. coli (ETEC), Enteroaggregative E. coli (EAEC), and Shiga toxin-producing E. coli (STEC) in Brassica oleracea cultivars in order to provide information on the assessment of diarrheagenic E. coli pathogenesis risk. Materials and Methods: 100 samples of vegetables were collected in Tehran, including cabbage, cauliflower, broccoli and Brussels sprouts. After homogenizing samples, enrichment was done in the EC broth medium. Five colonies of pure culture were used for DNA extraction. Pathotypes were identified by PCR using virulence genes. Results: The results showed that the prevalence of diarrheagenic E. coli strains was 7%. The EPEC prevalence was 3%, All EPEC isolates were atypical. The ETEC frequency was 3%, And the EAEC prevalence was 1%. Conclusion: These findings indicated that Brassica oleracea cultivars could be consideredas a source of contamination with diarrhea-causing E. coli strains.
- 22 February 2022
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 14 (1) , 84-89
Open AccessEvaluation of the frequency of Escherichia coli pathogroups in Brassica oleracea cultivars
Background and Objectives: Pathogenic diseases resulting from microbial contamination of food have been widely distrib- uted in many parts of the world. Among these, Escherichia coli is one of the most important foodborne pathogenic bacteria. Diarrhea is one of the major causes of children’s death in developing countries, with approximately 2 million deaths annually. The current study aimed to determine the frequency of diarrheagenic E. coli pathotypes such as Enteropathogenic E. coli (EPEC), Enterotoxigenic E. coli (ETEC), Enteroaggregative E. coli (EAEC), and Shiga toxin-producing E. coli (STEC) in Brassica oleracea cultivars in order to provide information on the assessment of diarrheagenic E. coli pathogenesis risk. Materials and Methods: 100 samples of vegetables were collected in Tehran, including cabbage, cauliflower, broccoli and Brussels sprouts. After homogenizing samples, enrichment was done in the EC broth medium. Five colonies of pure culture were used for DNA extraction. Pathotypes were identified by PCR using virulence genes. Results: The results showed that the prevalence of diarrheagenic E. coli strains was 7%. The EPEC prevalence was 3%, All EPEC isolates were atypical. The ETEC frequency was 3%, And the EAEC prevalence was 1%. Conclusion: These findings indicated that Brassica oleracea cultivars could be consideredas a source of contamination with diarrhea-causing E. coli strains.
- Open Access
- 9 August 2021
- Published by Brieflands in Jentashapir Journal of Cellular and Molecular Biology
- Vol. 12 (3)
Biofilm Formation Capability of Clinical Helicobacter pylori Isolates on MKN-45 Cells
Background: In vitro biofilm formation of H. pylori is demonstrated; however, its potential role in the persistent infection of the human stomach has not yet been addressed. Objectives: The aim of this study was to assess the biofilm formation of clinical H. pylori isolates on an epithelial cell line, a line that produces mucin. Methods: H. pylori isolates consisting of an efficient (19B) and a weak (4B) biofilm formation ability, were selected from screening of the clinical isolates. Their adhesion index was determined after 2h incubation with the semi-confluent monolayers of MKN-45 cells. Their biofilm formation was evaluated after 24 and 72 h incubation with MKN-45 cells using a modified adherence assay developed in this work. Production of biofilm was quantitatively assessed by CFU enumeration and qualitatively by the immunofluorescence, and scanning-electron-microscopic (SEM) methods. Due to the importance of mucin in the binding of H. pylori and biofilm formation, the binding strength of the mucin binding protein, MUC5AC, and MUC1 with docking was investigated using cluspro webserver. Results: Using MKN-45 epithelial cell line as a model, significant differences were observed between the adhesion index of 19B and 4B isolates. After 24h, both isolates were able to form biofilms with significantly higher numbers of CFU for the 19B isolate. These results were confirmed by immunofluorescence and SEM such that after 24h, a cluster of coccoid bacteria on the MKN-45 cells in the form of microcolonies was observed. The docking results showed that MUC5AC demonstrated the most favorable interaction with H. pylori urease and BabA with docking energy scores of -931.1 and -906.3 kcal.mol-1, respectively. Conclusions: By developing an appropriate in situ biofilm assay, we investigated biofilm formation by clinical H. pylori isolates on the MKN-45 epithelial cell line. The establishment of such an in-situ model for studying the biofilm formation ability of clinical isolates can also be used to study cell-bacteria interactions in the context of a complex biofilm and also as a model for drug screening applications.
- 9 August 2021
- Published by Brieflands in Jentashapir Journal of Cellular and Molecular Biology
- Vol. 12 (3)
Open AccessBiofilm Formation Capability of Clinical Helicobacter pylori Isolates on MKN-45 Cells
Background: In vitro biofilm formation of H. pylori is demonstrated; however, its potential role in the persistent infection of the human stomach has not yet been addressed. Objectives: The aim of this study was to assess the biofilm formation of clinical H. pylori isolates on an epithelial cell line, a line that produces mucin. Methods: H. pylori isolates consisting of an efficient (19B) and a weak (4B) biofilm formation ability, were selected from screening of the clinical isolates. Their adhesion index was determined after 2h incubation with the semi-confluent monolayers of MKN-45 cells. Their biofilm formation was evaluated after 24 and 72 h incubation with MKN-45 cells using a modified adherence assay developed in this work. Production of biofilm was quantitatively assessed by CFU enumeration and qualitatively by the immunofluorescence, and scanning-electron-microscopic (SEM) methods. Due to the importance of mucin in the binding of H. pylori and biofilm formation, the binding strength of the mucin binding protein, MUC5AC, and MUC1 with docking was investigated using cluspro webserver. Results: Using MKN-45 epithelial cell line as a model, significant differences were observed between the adhesion index of 19B and 4B isolates. After 24h, both isolates were able to form biofilms with significantly higher numbers of CFU for the 19B isolate. These results were confirmed by immunofluorescence and SEM such that after 24h, a cluster of coccoid bacteria on the MKN-45 cells in the form of microcolonies was observed. The docking results showed that MUC5AC demonstrated the most favorable interaction with H. pylori urease and BabA with docking energy scores of -931.1 and -906.3 kcal.mol-1, respectively. Conclusions: By developing an appropriate in situ biofilm assay, we investigated biofilm formation by clinical H. pylori isolates on the MKN-45 epithelial cell line. The establishment of such an in-situ model for studying the biofilm formation ability of clinical isolates can also be used to study cell-bacteria interactions in the context of a complex biofilm and also as a model for drug screening applications.
- Open Access
- 28 June 2021
- Published by Springer Nature in Gut Pathogens
- Vol. 13 (1) , 1-8
The penicillin binding protein 1A of Helicobacter pylori, its amoxicillin binding site and access routes
Background: Amoxicillin-resistantH. pyloristrains are increasing worldwide. To explore the potential resistance mechanisms involved, the 3D structure modeling and access tunnel prediction for penicillin-binding proteins (PBP1A) was performed, based on theStreptococcus pneumoniae, PBP 3D structure. Molecular covalent docking was used to determine the interactions between amoxicillin (AMX) and PBP1A.Results: The AMX-Ser368 covalent complex interacts with the binding site residues (Gly367, Ala369, ILE370, Lys371, Tyr416, Ser433, Thr541, Thr556, Gly557, Thr558, and Asn560) of PBP1A, non-covalently. Six tunnel-like structures, accessing the PBP1A binding site, were characterized, using the CAVER algorithm. Tunnel-1 was the ultimate access route, leading to the drug catalytic binding residue (Ser368). This tunnel comprises of eighteen amino acid residues, 8 of which are shared with the drug binding site. Subsequently, to screen the presence of PBP1A mutations, in the binding site and tunnel residues, in our clinical strains, in vitro assays were performed.H. pyloristrains, isolated under gastroscopy, underwent AMX susceptibility testing by E-test. Of the 100 clinical strains tested, 4 were AMX-resistant. The transpeptidase domain of thepbp1agene of these resistant, plus 10 randomly selected AMX-susceptible strains, were amplified and sequenced. Of the amino acids lining the tunnel-1 and binding site residues, three (Ser414Arg, Val469Met and Thr556Ser) substitutions, were detected in 2 of the 4 resistant and none of the sequenced susceptible strains, respectively.Conclusions: We hypothesize that mutations in amino acid residues lining the binding site and/or tunnel-1, resulting in conformational/spatial changes, may block drug binding to PBP1A and cause AMX resistance.
- 28 June 2021
- Published by Springer Nature in Gut Pathogens
- Vol. 13 (1) , 1-8
Open AccessThe penicillin binding protein 1A of Helicobacter pylori, its amoxicillin binding site and access routes
Background: Amoxicillin-resistantH. pyloristrains are increasing worldwide. To explore the potential resistance mechanisms involved, the 3D structure modeling and access tunnel prediction for penicillin-binding proteins (PBP1A) was performed, based on theStreptococcus pneumoniae, PBP 3D structure. Molecular covalent docking was used to determine the interactions between amoxicillin (AMX) and PBP1A.Results: The AMX-Ser368 covalent complex interacts with the binding site residues (Gly367, Ala369, ILE370, Lys371, Tyr416, Ser433, Thr541, Thr556, Gly557, Thr558, and Asn560) of PBP1A, non-covalently. Six tunnel-like structures, accessing the PBP1A binding site, were characterized, using the CAVER algorithm. Tunnel-1 was the ultimate access route, leading to the drug catalytic binding residue (Ser368). This tunnel comprises of eighteen amino acid residues, 8 of which are shared with the drug binding site. Subsequently, to screen the presence of PBP1A mutations, in the binding site and tunnel residues, in our clinical strains, in vitro assays were performed.H. pyloristrains, isolated under gastroscopy, underwent AMX susceptibility testing by E-test. Of the 100 clinical strains tested, 4 were AMX-resistant. The transpeptidase domain of thepbp1agene of these resistant, plus 10 randomly selected AMX-susceptible strains, were amplified and sequenced. Of the amino acids lining the tunnel-1 and binding site residues, three (Ser414Arg, Val469Met and Thr556Ser) substitutions, were detected in 2 of the 4 resistant and none of the sequenced susceptible strains, respectively.Conclusions: We hypothesize that mutations in amino acid residues lining the binding site and/or tunnel-1, resulting in conformational/spatial changes, may block drug binding to PBP1A and cause AMX resistance.
- Open Access
- 14 August 2020
- Published by Wiley in Helicobacter
- Vol. 25 (6) , e12731
The outward shift of clarithromycin binding to the ribosome in mutantHelicobacter pyloristrains
Objectives: Disruption of protein synthesis, by drug‐mediated restriction of the ribosomal nascent peptide exit tunnel (NPET), may inhibit bacterial growth. Here, we have studied the secondary and tertiary structures of domain V of the 23S rRNA in the wild‐type and mutant (resistant)H. pyloristrains and their mechanisms of interaction with clarithromycin (CLA).Methods: H pyloristrains, isolated from cultured gastric biopsies, underwent CLA susceptibility testing by E test, followed by PCR amplification and sequencing of domain V of 23S rRNA. The homology model of this domain inH pylori, in complex with L4 and L22 accessory proteins, was determined based on theE. coliribosome 3D structure. The interactions between CLA and 23S rRNA complex were determined by molecular docking studies.Results: Of the 70H pyloristrains, isolated from 200 dyspeptic patients, 11 (16%) were CLA‐resistant. DNA sequencing identified categories with no (A), A2142G (B), and A2143G (C) mutations. Docking studies of our homology model of 23S rRNA complex with CLA showed deviated positions for categories B and C, in reference to category A, with 12.19 Å and 7.92 Å RMSD values, respectively. In both mutant categories, CLA lost its interactions at positions 2142 and 2587 and gained two new bonds with the L4 accessory protein.Conclusion: Our data suggest that, in mutantH pyloristrains, once the nucleotides at positions 2142 and 2587 are detached from the drug, CLA interacts with and is peeled back by the L4 accessory protein, removing the drug‐imposed spatial restriction of the NPET.
- 14 August 2020
- Published by Wiley in Helicobacter
- Vol. 25 (6) , e12731
Open AccessThe outward shift of clarithromycin binding to the ribosome in mutantHelicobacter pyloristrains
Objectives: Disruption of protein synthesis, by drug‐mediated restriction of the ribosomal nascent peptide exit tunnel (NPET), may inhibit bacterial growth. Here, we have studied the secondary and tertiary structures of domain V of the 23S rRNA in the wild‐type and mutant (resistant)H. pyloristrains and their mechanisms of interaction with clarithromycin (CLA).Methods: H pyloristrains, isolated from cultured gastric biopsies, underwent CLA susceptibility testing by E test, followed by PCR amplification and sequencing of domain V of 23S rRNA. The homology model of this domain inH pylori, in complex with L4 and L22 accessory proteins, was determined based on theE. coliribosome 3D structure. The interactions between CLA and 23S rRNA complex were determined by molecular docking studies.Results: Of the 70H pyloristrains, isolated from 200 dyspeptic patients, 11 (16%) were CLA‐resistant. DNA sequencing identified categories with no (A), A2142G (B), and A2143G (C) mutations. Docking studies of our homology model of 23S rRNA complex with CLA showed deviated positions for categories B and C, in reference to category A, with 12.19 Å and 7.92 Å RMSD values, respectively. In both mutant categories, CLA lost its interactions at positions 2142 and 2587 and gained two new bonds with the L4 accessory protein.Conclusion: Our data suggest that, in mutantH pyloristrains, once the nucleotides at positions 2142 and 2587 are detached from the drug, CLA interacts with and is peeled back by the L4 accessory protein, removing the drug‐imposed spatial restriction of the NPET.
- Open Access
- 7 July 2019
- Published by Wiley in Helicobacter
- Vol. 24 (5) , e12628
New insights into resistance of Helicobacter pylori against third‐ and fourth‐generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations
Background: Fluoroquinolones hinder bacterial DNA replication by inhibiting DNA gyrase. However, mutations, in the QRDR segment of its A subunit (GyrA), cause antibiotic resistance. Here, the interactions of levofloxacin (LVX), gemifloxacin (GXN), and moxifloxacin (MXN) with Helicobacter pylori GyrA, in LVX‐resistant vs ‐sensitive strains, were studied.Methods: Levoflixacin‐sensitive (n = 4) and ‐resistant (n = 9) H pylori strains, randomly selected from another antibiotic susceptibility study, underwent PCR amplification of gyrA gene, spanning the QRDR segment. The amplified gene fragments were sequenced and aligned. The homology model of H pylori GyrA was built based on that of Escherichia coli, and energy minimization was done. The interaction patterns of LVX, GXN, and MXN with GyrA were analyzed via molecular docking studies.Results: Sequence alignment of the 13 studied strains, created 5 categories of strains: (A) wild type‐like (H pylori ATCC26695), (B) N87K‐only, (C) D91N‐only, (D) N87K + V94L, and (E) D91N + A97V mutations. The minimum inhibitory concentrations (MIC) for LVX‐sensitive (category A) and ‐resistant (categories B‐E) strains were via a different set of key residues, while MXN retained the lost contact (G35) in LVX‐resistant, category B strains.Conclusion: Using molecular docking tools, we identified the key residues responsible for interaction of GyrA with LVX, GXN, and MXN. In the presence of N87K‐only mutation, the loss of one of these contacts (ie, G35) led to full LVX resistance. Yet, GXN and MXN overcame this mutation, by retaining all key contacts with GyrA.
- 7 July 2019
- Published by Wiley in Helicobacter
- Vol. 24 (5) , e12628
Open AccessNew insights into resistance of Helicobacter pylori against third‐ and fourth‐generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations
Background: Fluoroquinolones hinder bacterial DNA replication by inhibiting DNA gyrase. However, mutations, in the QRDR segment of its A subunit (GyrA), cause antibiotic resistance. Here, the interactions of levofloxacin (LVX), gemifloxacin (GXN), and moxifloxacin (MXN) with Helicobacter pylori GyrA, in LVX‐resistant vs ‐sensitive strains, were studied.Methods: Levoflixacin‐sensitive (n = 4) and ‐resistant (n = 9) H pylori strains, randomly selected from another antibiotic susceptibility study, underwent PCR amplification of gyrA gene, spanning the QRDR segment. The amplified gene fragments were sequenced and aligned. The homology model of H pylori GyrA was built based on that of Escherichia coli, and energy minimization was done. The interaction patterns of LVX, GXN, and MXN with GyrA were analyzed via molecular docking studies.Results: Sequence alignment of the 13 studied strains, created 5 categories of strains: (A) wild type‐like (H pylori ATCC26695), (B) N87K‐only, (C) D91N‐only, (D) N87K + V94L, and (E) D91N + A97V mutations. The minimum inhibitory concentrations (MIC) for LVX‐sensitive (category A) and ‐resistant (categories B‐E) strains were via a different set of key residues, while MXN retained the lost contact (G35) in LVX‐resistant, category B strains.Conclusion: Using molecular docking tools, we identified the key residues responsible for interaction of GyrA with LVX, GXN, and MXN. In the presence of N87K‐only mutation, the loss of one of these contacts (ie, G35) led to full LVX resistance. Yet, GXN and MXN overcame this mutation, by retaining all key contacts with GyrA.
- 9 October 2018
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- Vol. 23 (1) , 16-21
Satureja khuzistanica Jamzad essential oil and its anti-candidal activities against clinical isolates of Candida albicans isolated from women with candidiasis
Satureja khuzistanica Jamzad is known as antiseptic and analgesic agent in folk medicine. The aim of this investigation was to evaluate the anti-candidal activity of S. khuzistanica aerial parts essential oil against clinical isolates of Candida albicans, which were isolated from women with chronic recurrent candidiasis. For this purpose, the chemical composition of hydro-distilled essential oil was determined by GC and GC-MS analysis. Then, the anti-candidal activity of essential oil and its main component (carvacrol) were determined. Carvacrol (94.1%) was the main component of essential oil, followed by β-bisabolene, p-cymene and γ-terpinene. S. khuzistanica essential oil had strong anti-candidal activity against clinical isolates of C. albicans via inhibition of germ tube formation and induction the huge punctures in the cytoplasmic structures. The cell membranes were intact in presence of essential oil or carvacrol. S. khuzistanica essential oil as the main source of carvacrol can be used for treatment of C. albicans related infections.
- 9 October 2018
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- Vol. 23 (1) , 16-21
Satureja khuzistanica Jamzad essential oil and its anti-candidal activities against clinical isolates of Candida albicans isolated from women with candidiasis
Satureja khuzistanica Jamzad is known as antiseptic and analgesic agent in folk medicine. The aim of this investigation was to evaluate the anti-candidal activity of S. khuzistanica aerial parts essential oil against clinical isolates of Candida albicans, which were isolated from women with chronic recurrent candidiasis. For this purpose, the chemical composition of hydro-distilled essential oil was determined by GC and GC-MS analysis. Then, the anti-candidal activity of essential oil and its main component (carvacrol) were determined. Carvacrol (94.1%) was the main component of essential oil, followed by β-bisabolene, p-cymene and γ-terpinene. S. khuzistanica essential oil had strong anti-candidal activity against clinical isolates of C. albicans via inhibition of germ tube formation and induction the huge punctures in the cytoplasmic structures. The cell membranes were intact in presence of essential oil or carvacrol. S. khuzistanica essential oil as the main source of carvacrol can be used for treatment of C. albicans related infections.
- 2 June 2017
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 62 (8) , 1890-1896
Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran
Background Treatment success of H. pylori eradication therapy has declined worldwide largely because of increased antimicrobial resistance. New therapeutic approaches are needed, especially for countries like Iran, where resistance to commonly used drugs is already widespread and traditional H. pylori therapies produce poor cure rates. Aim To review the results of quadruple therapy trials containing bismuth and furazolidone in Iran. Methods We searched PubMed, Google scholar as well as the references of all published papers for studies conducted in Iran, utilizing furazolidone in the treatment of H. pylori infections. The target population was four drug studies that utilized a combination of bismuth, furazolidone, amoxicillin, or tetracycline plus a proton pump inhibitor. Results Eighteen studies with 22 arms including 1713 subjects were found. The weighted mean cure rate for 14-day studies (six studies) using 200 mg b.i.d. furazolidone was 80% intention to treat (ITT) and 87% per protocol (PP). Studies using 100 mg b.i.d. (three studies) were less effective (weighted mean ITT cure rate = 67%). One small 14-day study with furazolidone 100 mg q.i.d. achieved cure rates of 94.5% ITT and PP. Conclusions Although furazolidone–bismuth quadruple therapy proved relatively effective in Iran, furazolidone-containing regimens remain to be optimized. Based on these data and results from China, it appears likely that 14-day therapy containing furazolidone 100 mg t.i.d. or q.i.d. is likely to provide the highest cure rates with lowest side effects; this remains to be experimentally tested. Detailed suggestions for further development of furazolidone-containing regimens are provided.
- 2 June 2017
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 62 (8) , 1890-1896
Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran
Background Treatment success of H. pylori eradication therapy has declined worldwide largely because of increased antimicrobial resistance. New therapeutic approaches are needed, especially for countries like Iran, where resistance to commonly used drugs is already widespread and traditional H. pylori therapies produce poor cure rates. Aim To review the results of quadruple therapy trials containing bismuth and furazolidone in Iran. Methods We searched PubMed, Google scholar as well as the references of all published papers for studies conducted in Iran, utilizing furazolidone in the treatment of H. pylori infections. The target population was four drug studies that utilized a combination of bismuth, furazolidone, amoxicillin, or tetracycline plus a proton pump inhibitor. Results Eighteen studies with 22 arms including 1713 subjects were found. The weighted mean cure rate for 14-day studies (six studies) using 200 mg b.i.d. furazolidone was 80% intention to treat (ITT) and 87% per protocol (PP). Studies using 100 mg b.i.d. (three studies) were less effective (weighted mean ITT cure rate = 67%). One small 14-day study with furazolidone 100 mg q.i.d. achieved cure rates of 94.5% ITT and PP. Conclusions Although furazolidone–bismuth quadruple therapy proved relatively effective in Iran, furazolidone-containing regimens remain to be optimized. Based on these data and results from China, it appears likely that 14-day therapy containing furazolidone 100 mg t.i.d. or q.i.d. is likely to provide the highest cure rates with lowest side effects; this remains to be experimentally tested. Detailed suggestions for further development of furazolidone-containing regimens are provided.